JHOClass I
Electrophoretic Separation, Lipoproteins
21 CFR 862.1475 / Clinical Chemistry
JHO is the FDA product code for Electrophoretic Separation, Lipoproteins, a class I device type, regulated under 21 CFR 862.1475. As of , FDA records hold 26 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- JHO
- Device name
- Electrophoretic Separation, Lipoproteins
- Regulation
- 21 CFR 862.1475
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 26
- Ingested recalls
- 0
Clearances, product code JHO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 1 |
| 1979 | 2 |
| 1980 | 1 |
| 1984 | 1 |
| 1985 | 1 |
| 1987 | 1 |
| 1988 | 1 |
| 1989 | 1 |
| 1994 | 2 |
| 1996 | 3 |
| 1997 | 1 |
| 1998 | 3 |
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 4 |
Applicants with the most clearances
Product code JHO| Applicant | Clearances |
|---|---|
| Helena Laboratories, Corp. | 15 |
| Beckman Instruments, Inc. | 2 |
| Morax | 2 |
| Quantimetrix Corp. | 2 |
| Corning Medical & Scientific | 1 |
| Gelman Sciences, Inc. | 1 |
| Sebia | 1 |
| Strategic Diagnostics, Inc. | 1 |
| Zaxis, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
